Cataract/Anterior Segment
Ocular Surface Disease

Preop DED often undiagnosed or treated in cataract surgery cases

Posted on

A noninterventional, retrospective study of cataract patients in American Academy of Ophthalmology IRIS® Registry found that 30% of the study population were diagnosed with preoperative dry eye disease (DED) and only 3% of those received DED treatment within 3 months of surgery, according to data presented at 2020 AAO Virtual.

Sixty-six percent of those treated received a premium or advanced technology intraocular lens (AT-IOLs), with patients having 2.1 greater odds of receiving DED treatment when given an AT-IOL.

For the study, the researchers used the IRIS Registry to determine prevalence of preoperative DED diagnosis and treatment in the United States, and the association between treatment and receiving AT-IOL. For the study of cataract patients between January 2016 and March 2018, the DED diagnoses were identified by ICD-9/ICD-10 codes. Treatments included procedures, such as eyelid heat therapy, punctal plugs, and amniotic membrane, or medications, such as cyclosporine A or lifitegrast, within 12 weeks preoperatively. The majority of eyes treated (86.3%) used topical immunomodulators, while the most common coded procedure was closure of the lacrimal punctum with a plug (10.2%).

Results showed that 26,543 cataract patients (29.5%) were diagnosed with DED and 3.0% of those diagnosed received treatment. Eyes with monofocal IOLS had the lowest percentage of DED-treated eyes (<2.0%). Nearly two-thirds of eyes treated for DED received premium IOLS and eyes receiving extended depth of focus (EDOF) IOLs had the highest percentage (~5%) of DED-treated eyes.

Starr CS, et al. Prevalence of prospective dry eye diagnosis and treatment among cataract patients: An AAO IRIS Registry analysis. Presented at: AAO 2020 Virtual [Session: PO105].

Related Articles
How do patients use social media after cataract surgery?
Jul 29, 2021
Cataract surgery reduces average number ocular hypotensive medications
Jul 22, 2021
American Academy of Ophthalmology and ASCRS Urge Aetna to Reverse Disruptive New Policy on Cataract Surgery
Jul 05, 2021